Form 10-Q · Quarterly report
Live Nation Entertainment 10-Q, filed Nov 5, 2026
- Filed
- CIK
- 0001335258
- Accession no.
- 0001335258-26-000053
Summary
Live Nation Entertainment reported record third-quarter 2026 results, with consolidated revenue up 19% to $10.1 billion and operating income up 13% to $892.0 million, as fan count rose 19% to 61.1 million and ticket sales paced 13% ahead of the prior year for 2026 events. For the first nine months of 2026, revenue rose 14% to $21.6 billion but operating income fell 25% to $1.0 billion, primarily due to governmental investigations and litigation that included a $450 million accrual.
Key points
- Third-quarter revenue rose 19% to $10.1 billion and operating income rose 13% to $892.0 million, with all three reporting segments growing AOI double digits.
- Concerts revenue grew 20% to $8.7 billion on fan count up 19% to 61.1 million and events up 7% to about 13,100.
- Ticketing fee-bearing ticket sales rose 10% to 98.3 million and fee-bearing GTV rose 13% to $11.2 billion; Sponsorship & Advertising revenue rose 14% to $505.7 million.
- First-nine-month operating income fell 25% to $1.0 billion, primarily due to governmental investigations and litigation that included a $450 million accrual.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Executive Overview The third quarter of 2026 yielded our highest consolidated operating income and AOI results ever. All three of our reporting segments grew AOI by double digits, underlining sustained consumer demand for the live experience. As well, all of our key performance indicators are meaningfully up year-over-year, giving us confidence in a successful conclusion to 2026. Double-digit ticket sales growth versus 2025 across all of our major markets for amphitheater, arena and stadium sales demonstrates strong fan demand. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.